Nature Communications Archives

Dr. Josep Tabernero en el laboratorio con bata blanca VHIO

Novel T-cell bispecific antibody shows promise in retriggering the immune response to combat metastatic colorectal cancer

First results of two multi-center international Phase 1 dose-escalation and -expansion clinical trials of novel T-cell bispecific antibody cibisatamab as…

The promise of Immune RECIST as evidence-based response criteria for cancer immunotherapy

Recently published open access in the journal Nature Communications*, an invited Comment article first authored by VHIO’s Elena Garralda, sets…